Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Clinical Transplants|January 1, 1989
Bone marrow transplantation in Basel: single center experience from 1973 to 1989B Speck, C Nissen, A Tichelli, et al.
Schweizerische Medizinische Wochenschrift|September 30, 1989
[Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a]A Tichelli, A Gratwohl, F Delacrétaz, et al.
Schweizerische Medizinische Wochenschrift|March 23, 1991
[Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)]A Gratwohl, H Dazzi, A Tichelli, et al.
American Journal of Clinical Pathology|January 1, 1990
Evaluation of the Sysmex R-1000. An automated reticulocyte analyzerA Tichelli, A Gratwohl, A Driessen, et al.
Blood|October 1, 1988
Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabineR A Larson, M Wernli, M M Le Beau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1995
Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center studyT Egger, A Gratwohl, A Tichelli, et al.
Bone Marrow Transplantation|March 7, 2003
Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effectiveM J Bargetzi, J Passweg, E Baertschi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.
Cancer|January 5, 1999
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinomaF Recker, M K Kwiatkowski, T Piironen, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
Pageof 6